TW200515912A - Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep - Google Patents
Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleepInfo
- Publication number
- TW200515912A TW200515912A TW093126564A TW93126564A TW200515912A TW 200515912 A TW200515912 A TW 200515912A TW 093126564 A TW093126564 A TW 093126564A TW 93126564 A TW93126564 A TW 93126564A TW 200515912 A TW200515912 A TW 200515912A
- Authority
- TW
- Taiwan
- Prior art keywords
- pain
- sleep
- improvement
- treatment
- oxcarbazepine
- Prior art date
Links
Abstract
The present invention provides for novel uses of the carbamazepine derivative of formula I, and its pharmaceutically acceptable salts, in particular an improved regimen for the administration of the carbamazepine derivative of formula I and the pharmaceutically acceptable salts thereof for the treatment of patients suffering from pain, in particular neuropathic pain, especially diabetic neuropathic pain, and the improvement of sleep; the use of oxcarbazepine for the manufacture of a pharmaceutical composition for the treatment of pain or the manufacture of a pharmaceutical composition for the improvement of sleep in human patients suffering from chronic pain; pharmaceutical compositions comprising oxcarbazepine as sole active ingredient for the treatment of pain or for the improvement of sleep in human patients suffering from chronic pain and to packages comprising a pharmaceutical composition comprising as sole active ingredient oxcarbazepine together with instructions for the treatment of pain or together with instructions for improvement of sleep in human patients suffering from chronic pain.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0320637A GB0320637D0 (en) | 2003-09-03 | 2003-09-03 | Organic compounds |
US53737804P | 2004-01-16 | 2004-01-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200515912A true TW200515912A (en) | 2005-05-16 |
Family
ID=28686842
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW093126564A TW200515912A (en) | 2003-09-03 | 2004-09-02 | Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep |
Country Status (4)
Country | Link |
---|---|
CN (1) | CN1845743A (en) |
GB (1) | GB0320637D0 (en) |
TW (1) | TW200515912A (en) |
ZA (1) | ZA200601502B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4003357A1 (en) * | 2019-07-23 | 2022-06-01 | Astellas Pharma Global Development, Inc. | Methods of treating sleep disorders associated with pain |
-
2003
- 2003-09-03 GB GB0320637A patent/GB0320637D0/en not_active Ceased
-
2004
- 2004-09-02 TW TW093126564A patent/TW200515912A/en unknown
- 2004-09-02 CN CN 200480025051 patent/CN1845743A/en active Pending
-
2006
- 2006-02-21 ZA ZA200601502A patent/ZA200601502B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200601502B (en) | 2007-04-25 |
CN1845743A (en) | 2006-10-11 |
GB0320637D0 (en) | 2003-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA04004842A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1. | |
MXPA04004837A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1. | |
IL161154A0 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
WO2006133941A3 (en) | Cannabinoid active pharmaceutical ingredient for improved dosage forms | |
WO2008027557A3 (en) | Topiramate compositions and methods of enhancing its bioavailability | |
TW200736223A (en) | N-(pyridin-2-yl)-sulfonamide derivatives | |
MY144897A (en) | 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists | |
MXPA05007857A (en) | Indole-derivative modulators of steroid hormone nuclear receptors. | |
MX2009002314A (en) | Pharmaceutical compositions comprising hgh for oral delivery. | |
EP2392322A3 (en) | Dosing regimes for trans-clomiphene | |
UA92498C2 (en) | Cannabinoid active pharmaceutical ingredient for improved dosage forms | |
MX2009011900A (en) | Diabetic wound healing. | |
WO2002088100A3 (en) | Deuterated 3-piperidinopropiophenone and medicaments containing said compounds | |
RS44204A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
TNSN06072A1 (en) | Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep | |
EA201100916A1 (en) | COMBINATION OF INSULIN WITH TRIAZINE DERIVATIVES AND THEIR APPLICATION FOR THE TREATMENT OF DIABETES | |
IL179177A (en) | Pharmaceutical composition comprising acyclovir and a delivery agent, a dosage unit, use of acyclovir in the preparation of the pharmaceutical composition, use of the pharmaceutical composition in the preparation of a medicament and a method of preparing the pharmaceutical composition | |
RU2007119067A (en) | MEANS FOR TREATMENT OF AN IRRITATED INTESTINAL SYNDROME WITH PREVENTION OF DIARRHEA | |
RS44304A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
TW200515912A (en) | Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep | |
TW200626133A (en) | Oral medication for twice-daily administration | |
WO2003043632A3 (en) | Use of bisindolmaleimide and gemcitabine for the treatment of cancer | |
BRPI0503488A (en) | treatment agent for irritable bowel syndrome with predominant diarrhea | |
DE50311479D1 (en) | PHARMACEUTICAL COMPOSITION, CONTAINING OXCARBAZEPINE WITH CONTROLLED ACTIVE INGREDIENTS | |
EA200501366A1 (en) | MEDICINE |